THE ROLE OF THE IMMUNE SYSTEM AND ORAL FLUID AND BLOOD ANTIMICROBIAL PEPTIDES IN PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS
Abstract
Immunological mechanisms play the leading role in the pathogenesis of inflammatory destructive processes in periodontium. That's why clinical manifestations of chronic generalized periodontitis depend not so much on pathogenicity and virulence of corresponding microflora but on the character of bacterial-gostal interrelations, that is, in many respects - on the degree of macroorganism reactivity, which is determined by the functional state of immune system. Consequently, an important step in understanding the nature of inflammatory periodontal diseases is the study of those immunological factors (cytokines and antibodies) as well as enzymes that can cause shifts in the morpho-functional state of the supporting apparatus of the tooth, as well as cause the corresponding clinic of the indicated pathology.
Similar Articles
-
BIOCHEMICAL CHANGES OF CHRONIC GENERALIZED PERIODONTITIS IN CHRONIC VIRAL HEPATITIS B, C AND MIXED INFECTIONS
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2023) / Nazarova Nodira Sharipovna, Shukurov Sherzod Shukhratovich, -
EFFECTS OF PERINDOPRIL INITIATION ON SERUM CREATININE AND POTASSIUM LEVELS FOLLOWING ACUTE CORONARY SYNDROME (ACS)
-
Emergency Preparedness and Innovative Response Plan for Smooth Congregations during COVID-19 pandemic: An Urgent Need for Comprehensive Approaches to Tactically Resolve Risk of SARS-CoV-2 or MERS-CoV Transmission
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2021) / Umar Saeed , Zahra Zahid Piracha , Sara Rizwan Uppal , Muhammad Saad Uppal , Aftab Ahmad Khan , Muhammad Erfan Khattak, -
EFFECTIVENESS OF SURGICAL TREATMENT OF HORIZANTAL STRABISMUS IN CHILDREN
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2023) / Boboev Saidavzal Abdurakhmonovich, Boboevа Sitora Saidavzalzoda, Kosimov Rayim Erkinovich, Shokhida Mubashirovna Dadamukhamedova, -
A New Source Of Biologically Active Substances Used In The National Economy And Medicine
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2020) / Yusupova S.S., Holmurodova D.K., Kiyamova D.Sh. , -
Features Antihypertensive Therapy Obesity
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2020) / Ishankulova Nasiba Nurmamadovna , Abdushukurova Komila Abdurasulovna, -
Forensic Description Of Cases Of Noletal Asphyxia
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2021) / Z.A.Giyasov, S.A.Khakimov, -
Forensic Description Of Cases Of Noletal Asphyxia
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2021) / Z.A.Giyasov, S.A.Khakimov, -
EXPLORING THE POTENT ANTIMICROBIAL ACTIVITIES AND MECHANISM OF ACTION OF PETIVERIA ALLIACEA STEM EXTRACT
References
Акбиева Д.С. Роль цитокинов в развитии заболеваний гастродуоденальной зоны // Современные проблемы науки и образования. – 2017. – № 2. С 64-69
Saperas E., Tache Y. Central interleukin-1 beta-induced inhibitionof acid secretion in rats: specificity of action. Life Sci. 1993;52: 785–792.
Sims J.E., Nicklin M.J., Bazan J.F., Barton J.L., Busfield S.J.,Ford J.E., Kastelein R.A., Kumar S., Lin H., Mulero J.J., Pan J.,Pan Y., Smith D.E., Young P.R. A new nomenclature for IL-1-family genes. Trends Immunol. 2001; 22: 536–537.
Novye chleny tsitokinov interleikina-1 i ikh rol' v destruktivnykhvospalitel'nykh zabolevaniyakh. Med. al'manakh. 2011;5 (18): 274–276.
. Ferrari D., Pizzirani C., Adinolfi E.. Lemoli R.M., Curti A.,IdzkoM., Panther E., Di Virgilio F. The P2X7 receptor:a key player in ИЛ-1 processing and release. J. Immunol. 2006;176: 3877–3883.
Казеко Л.А. Возможности диагностики заболеваний периодонта с использованием противомикробных пептидов слюны и десневой жидкости // Современная стоматология. - 2016. - №.1. - С.11-16.
Пантелеев П. В., Болосов И. А., Баландин С. В., Овчинникова Т. В. Строение биологические функции Р-шпилечных антимикробных пептидов. Журнал «АКТА НАТУРЭ»-2015. - Т. 7. - № 1 (24). - С.37-47.
Ali Adem Bahar, Dacheng Ren. Antimicrobial Peptides//Pharmaceuticals (MDPI). - 2013. - Vol.6 (12). - P.1543-1575.
Alexandre L. Pereira, Gilson C. Franco, Sheila C. Cortelli.. Influence of Periodontal Status and Periodontopathogens on Levels of Oral Human P-defensin-2 in Saliva // Journal of Periodontology.-2013. - V.84. - №1. - P.1445-1453.
Henrik Dommisch S0ren Jepsen. Diverse Functions of Defensins and Other Antimicrobial Peptides in Periodontal Tissues //Journal of Periodontology. -2015.- V.69. - №1. -P.96-110.
Вавилова Т.П., Янушевич О.О., Островская О.Г. Слюна. Аналитические возможности и перспективы. М.: БИНОМ; 2014.
Будихина A.C., Пинегин Б.В. Дефензины — многофункциональные катионные пептиды человека. Иммунопатология, аллергология, ин- фектология. 2008;2:31-40.
Ericksen B, Wu Z, Lu W, Lehrer RI. Antibacterial activity and specificity of the six human alfa-defensins. Antimicrobial Agents and Chemotherapy. 2005;49(1):269-275.doi: 10.1128/AAC.49.1.269-275.2005.
Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T. Role of в-defensins in oral epithelial health and disease. Medical Molecular Morphology. 2007;40(4):79-184.doi: 10.1007/s00795-007-0381-8.
Lehrer R.I., Lu W. а-Defensins in human innate immunity // Immunol. Rev. — 2012. — Vol. 245, N 1. — P. 84-112.
Гришин Д.В., Соколов Н.Н. Дефензины — естественные пептидные антибиотики высших эукариот // Биомедицинская химия. 2014. Т. 60. № 4. С. 438—447.
Gursoy U.K., Kononen E., Luukkonen N., Uitto V.J. Human neutrophil defensins and their effect on epithelial cells // J Periodontol. 2013. Vol. 84. P. 126—133
Пешкова Э.К., 2016; Пешкова Э.К. Морфофункциональная оценка особенностей зубочелюстного комплекса у больных с гипотиреозом и без патологии щитовидной железы: дис. ... канд.мед.наук /Э.К. Пешкова, ФГАОУ ВО «Белгородский государственный национальный исследовательский университет», Белгород, 2016. - 103 с.
